Research News and Research

RSS

Christian Science Monitor examines focus on combatting hunger

The Christian Science Monitor looks at one idea about why hunger is receiving a lot of attention in the international arena. Kanayo Nwanze, the Kenyan "who recently became president of the United Nations' International Fund for Agricultural Development (IFAD) says globalization has made the hunger and rural poverty that always pulled on the heartstrings an international security issue," according to the publication.

3 Nov 2009

Financial results for third-quarter 2009 announced by Combinatorx

CombinatoRx, Incorporated today reported financial results for the third quarter ended September 30, 2009.

3 Nov 2009

Exact Sciences announces financial results for the third quarter ended Sept. 30, 2009

Exact Sciences Corp. today announced its financial results for the third quarter ended Sept. 30, 2009.

3 Nov 2009

Arrowhead Research updates its shareholders

Arrowhead Research Corporation’s (NASDAQ: ARWR) President and Chief Executive Officer today issued the following letter to the Company’s shareholders.

3 Nov 2009

Hetero bags 4 million dollar contract from Hard to Treat Diseases

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com) Mellow Hope operating subsidiary is in process of finalizing contract details with Hetero Ltd., www.heterodrugs.com one of the largest pharmaceutical manufacturers in India. This contract has been in the works since March 2009, and its finalization promises solid sales boost for Hard to Treat Diseases.

3 Nov 2009

NIH awards Trevena $7.65M Grand Opportunity grant

Trevena Inc., a leader in the discovery of G-protein coupled receptor (GPCR) biased ligands announced today that it was awarded a $7.65 million Grand Opportunity (GO) Grant by the office of the director of the National Institutes of Health (NIH). This grant will further fund Trevena’s work to identify and characterize functionally selective biased ligands for a wide range of GPCRs.

3 Nov 2009

NIH awards $4 million research grant to AllTranz

AllTranz, Inc., a specialty pharmaceutical company focused on developing drugs to treat a variety of neurologic and inflammatory disorders, today announced that it has been awarded a $4 million research grant from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to advance the company’s transdermal tetrahydrocannabinol (THC) patch for the treatment of marijuana dependence and withdrawal.

3 Nov 2009

First Edition: November 3, 2009

Today's headlines focus on the the timing, politics, costs and contents of pending health overhaul bills, as well as a soon-to-be released GOP alternative.

3 Nov 2009

Akonni Biosystems announces worldwide launch of their TruTip product line

Akonni Biosystems, a molecular diagnostic (MDx) company focused on providing rapid and highly scalable solutions for research and infectious disease testing, today announced the worldwide launch of their TruTip product line for extracting DNA and RNA from samples with volumes ranging from 100 µl to 1000 µl or more.

3 Nov 2009

Researchers identify part of the brain that responds to both facial and vocal expressions of emotion

Researchers at the University of York have identified a part of the brain that responds to both facial and vocal expressions of emotion.

3 Nov 2009

Acorda Therapeutics' financial results for the third quarter of 2009 and update on Fampridine-SR

Acorda Therapeutics, Inc. today announced its financial results for the third quarter of 2009.

3 Nov 2009

Caucasian women may suffer from RLS up to four times more than African-American women

New research shows that Caucasian women may suffer from restless legs syndrome (RLS), a sleep disorder characterized by the strong urge to move the legs, up to four times more than African-American women. The study, presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that, overall, non-African-American (NAA) patients experienced RLS four times more often than African-Americans (AA).

3 Nov 2009

Risk of postoperative visual loss is highest after heart surgery

Imagine waking up after surgery to find out you have lost your sight—permanently. Although rare, postoperative visual loss is a well-recognized complication of anesthesia and surgery that is more common after certain types of procedures and in some groups of patients, according to a study in the November issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

3 Nov 2009

Texas State University researchers to evaluate the effects of ALKA-V6 on animal organisms

Texas State University and Orizon Research Institute announced the signing of an agreement today that will permit University Researchers to continue efforts through in vivo testing to further determine the potential and effectiveness of ALKA-V6, a compound which has shown remarkable ability to kill cancer cells and inhibit the HIV virus in laboratory experiments.

3 Nov 2009

Nasal positive airway pressure therapy for sleep apnea golfers may improve their game

Golfers who undergo treatment for sleep apnea may improve their golf game as well as their overall health, shows new research. A new study presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that golfers with obstructive sleep apnea (OSA) who received nasal positive airway pressure (NPAP) for their disorder improved their daytime sleepiness scores and lowered their golf handicap by as much as three strokes.

3 Nov 2009

Adults who experienced physical abuse as children at a higher risk of osteoarthritis, says study

Adults who had experienced physical abuse as children have 56 per cent higher odds of osteoarthritis compared to those who have not been abused, according to a new study by University of Toronto researchers.

3 Nov 2009

Two cancer-causing genes together can lead to aggressive leukaemia

Two genes, each one of which is known to cause cancer on its own, together can lead to aggressive leukaemia. This is the conclusion from new research carried out on gene-modified mice at the Sahlgrenska Academy at the University of Gothenburg, Sweden. The discovery has surprised scientists, and may lead to new treatments.

3 Nov 2009

Smokers with systemic lupus erythematosus at greater risk of skin damage and rashes

As if there weren't enough reasons to stop smoking, a team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) have just found another. A study led by Dr. Christian A Pineau, Co-Director of the Lupus and Vasculitis clinic at the MUHC, has clearly linked skin damage and rashes to smoking in people with systemic lupus erythematosus (SLE). The study was published in a recent issue of the Journal of Rheumatology.

3 Nov 2009

High blood pressure and an innate pro-inflammatory cytokine response contribute to Alzheimer's disease

High blood pressure, evidence of arterial disease and markers of inflammation in the blood in middle age appear more common in individuals whose parents have Alzheimer's disease than in individuals without a parental history of the condition, according to a report in the November issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

3 Nov 2009

Unintentional hot tub-related injuries increases by 160%, says study

Though hot tubs, whirlpools and spas are widely used for relaxation and fun, they can pose serious risk for injury. Over the past two decades, as recreational use of hot tubs has increased, so has the number of injuries. A recent study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital found that from 1990-2007, the number of unintentional hot tub-related injuries increased by 160 percent, from approximately 2,500 to more than 6,600 injuries per year.

3 Nov 2009

Research News and Research

Christian Science Monitor examines focus on combatting hunger

Financial results for third-quarter 2009 announced by Combinatorx

Exact Sciences announces financial results for the third quarter ended Sept. 30, 2009

Arrowhead Research updates its shareholders

Hetero bags 4 million dollar contract from Hard to Treat Diseases

NIH awards Trevena $7.65M Grand Opportunity grant

NIH awards $4 million research grant to AllTranz

First Edition: November 3, 2009

Akonni Biosystems announces worldwide launch of their TruTip product line

Researchers identify part of the brain that responds to both facial and vocal expressions of emotion

Acorda Therapeutics' financial results for the third quarter of 2009 and update on Fampridine-SR

Caucasian women may suffer from RLS up to four times more than African-American women

Risk of postoperative visual loss is highest after heart surgery

Texas State University researchers to evaluate the effects of ALKA-V6 on animal organisms

Nasal positive airway pressure therapy for sleep apnea golfers may improve their game

Adults who experienced physical abuse as children at a higher risk of osteoarthritis, says study

Two cancer-causing genes together can lead to aggressive leukaemia

Smokers with systemic lupus erythematosus at greater risk of skin damage and rashes

High blood pressure and an innate pro-inflammatory cytokine response contribute to Alzheimer's disease

Unintentional hot tub-related injuries increases by 160%, says study

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms